Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1996
06/05/1996EP0714510A1 Natural killer cell-specific antigen and antibodies that identify the same
06/05/1996EP0714449A1 Oligonucleotide modulation of protein kinase c
06/05/1996EP0714442A1 Recombinant alternaria alternata allergenes
06/05/1996EP0714441A1 Recombinant cladosporium herbarum allergens
06/05/1996EP0714440A1 T cell epitopes of ryegrass pollen allergen
06/05/1996EP0714439A1 Recombinant humanized anti-human immunodeficiency virus antibody
06/05/1996EP0714438A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells
06/05/1996EP0714435A1 Pro-urokinase mutants
06/05/1996EP0714411A1 Bioadhesive starches and process for their preparation
06/05/1996EP0714410A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents
06/05/1996EP0714409A1 Antibodies
06/05/1996EP0714408A1 Tryptase inhibitor
06/05/1996EP0714407A1 Composition and methods using nitroxides to avoid oxygen toxicity
06/05/1996EP0714406A1 Refolding of polypeptides like recombinant insulin-like growth factor igf-i
06/05/1996EP0714405A1 Therapeutic and diagnostic agents for amyloidosis
06/05/1996EP0714404A1 Anti-inflammatory peptides
06/05/1996EP0714399A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors
06/05/1996EP0714308A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
06/05/1996EP0714290A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
06/05/1996EP0586596A4 Device and method for the analysis of rolling blood leukocytes and identifying inhibitors and promoters
06/05/1996EP0555229B1 Accumulation of amino acids and peptides into liposomes
06/05/1996EP0497825B1 Anti-viral material
06/05/1996CN1124040A Adenoviral vectors of animal origin and use thereof in gene therapy
06/05/1996CN1124012A Arylating medicaments
06/05/1996CN1123699A Hipophae rhamnoides superoxidant dismutases and small molecular oxidation resistant compound
06/05/1996CN1123698A Swine WBC interferon injection and its preparation
06/05/1996CN1031948C Process for preparing antibiotic GE2270
06/04/1996US5523469 Reacting alkali metal sulfite on 1-(1-bromoethyl)-3-nitrobenzene; conversion to potassium salt; conversion to benzylquinium salt; then quaternization
06/04/1996US5523456 Anticarcinogenic agents
06/04/1996US5523395 Detecting sialic acids such as n-acetylneuraminic acid and n-glycolylneuraminic acid and their complex sugars
06/04/1996US5523391 For treating leukemia, uterine cancer
06/04/1996US5523389 Inhibitors of human immunodeficiency virus
06/04/1996US5523313 Hypotensive agents; cardiotonic agents; inhibitors of neutral metalloendopeptidases; vasodilation; heart failure and renal insufficiency
06/04/1996US5523308 Peptidyl heterocycles useful in the treatment of thrombin related disorders
06/04/1996US5523292 Method of preventing restenosis following coronary angioplasty
06/04/1996US5523291 Implant comprising elastin, collagen and a biocompatible carrier
06/04/1996US5523290 Antiproliferation factor
06/04/1996US5523289 Renin inhibitor
06/04/1996US5523288 Concurrently administering protein product and polymyxin b to treat infections caused by escherichia, providencia or pseudomonas species
06/04/1996US5523287 Thrombin-inhibitory protein from assassin bugs
06/04/1996US5523232 Use of restriction endonucleases against viruses, including HIV
06/04/1996US5523227 Gene actiavators
06/04/1996US5523225 DNA sequence encoding human cystathionine β-synthase
06/04/1996US5523088 Inactivated avian polyomavirus vaccine in psittacine birds
06/04/1996US5523085 Monoclonal antibody in destruction of small cell lung carcinoma
06/04/1996US5523084 Enhancing the anti-tumor effect of melphalan by prior administration of L-amino acid oxidase with or without intermediate administration of anti-L-amino acid oxidase antibody
06/04/1996CA2059541C Method of preparing a plasmid having both the ability to express a retroviral gene and the ability to process expression products after translation, the resultant plasmid and expression products thereof
06/02/1996CA2164165A1 Composition for prophlaxis or treatment of pulmonary circulatory diseases
05/1996
05/31/1996CA2163925A1 Chimeric proteins having fibrinolytic and thrombin-inhibiting properties
05/30/1996WO1996016183A1 Suicide genes and combinations of pyrimidine nucleoside and nucleobase analogues with suicide genes for gene therapy
05/30/1996WO1996016181A1 Expression plasmids for yeasts
05/30/1996WO1996016179A1 Enzyme gene therapy catalysing prodrug extracellular conversion
05/30/1996WO1996016178A1 Immunogens for stimulating mucosal immunity
05/30/1996WO1996016176A1 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4
05/30/1996WO1996016175A2 Lgmd gene coding for a calcium dependent protease
05/30/1996WO1996016173A2 Modified proteinase inhibitors
05/30/1996WO1996016170A2 Proteins involved in the regulation of cell-cell adhesion and uses thereof
05/30/1996WO1996016169A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
05/30/1996WO1996016088A1 Protein affecting katp channels
05/30/1996WO1996016087A1 G-protein coupled receptor
05/30/1996WO1996016086A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
05/30/1996WO1996016085A1 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
05/30/1996WO1996016084A2 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells
05/30/1996WO1996016083A1 Peptides endowed with antiinflammatory activity
05/30/1996WO1996016081A1 Bradykinin antagonist peptides containing indane-substituted amino acids
05/30/1996WO1996016080A1 Human neutrophil elastase inhibitors
05/30/1996WO1996016079A2 Alpha-ketoamide derivatives as cathepsin l inhibitor
05/30/1996WO1996016078A1 Method of making a library of compounds
05/30/1996WO1996016075A1 Antibiotic cryptdin peptides and methods of their use
05/30/1996WO1996016074A1 Double-stranded oligonucleotide and carcinostatic agent containing the same as active ingredient
05/30/1996WO1996016027A1 Matrix metalloprotease inhibitors
05/30/1996WO1996015816A2 Stable n-terminally linked dtpa:protein compositions and methods
05/30/1996WO1996015815A1 Microcapsules, method of making and their use
05/30/1996WO1996015812A1 Use of neuregulins as modulators of cellular communication
05/30/1996WO1996015810A1 Monofunctional and/or polyfunctional polylysine conjugates
05/30/1996WO1996015808A1 Method for making a medicament for treating secondary immunodeficiency
05/30/1996WO1996015806A1 Human choline acetyltransferase
05/30/1996WO1996015805A1 Hemoglobin therapy in hemodialysis
05/30/1996WO1996015804A1 Acylated insulin analogs
05/30/1996WO1996015803A1 SELECTIVE ACYLATION OF ε-AMINO GROUPS
05/30/1996WO1996015802A1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
05/30/1996WO1996015800A1 Method for treating secondary immunodeficiency
05/30/1996WO1996015799A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease
05/30/1996WO1996015797A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
05/30/1996WO1996015781A1 Use of nitric oxide-releasing agents for reducing metastasis risk
05/30/1996WO1996015780A1 Compositions and methods for preventing and treating allograft rejection
05/30/1996WO1996015777A1 Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy
05/30/1996WO1996015758A2 Methods for stimulating erythropoiesis using thrombopoietin
05/30/1996WO1996012807A3 Hepatitis e virus antigens and uses therefor
05/30/1996WO1996005300A3 Or-1 on orphan receptor belonging to the nuclear receptor family
05/30/1996DE4431121A1 Prodn. of conformation-stabilised calcitonin derivs. having increased activity
05/30/1996DE19541284A1 Verfahren zur Immunmodulation Methods for immunomodulation
05/30/1996CA2205807A1 Fusion proteins with cytotoxic activity against cells overexpressing erbb2-4
05/30/1996CA2205593A1 Enzyme gene therapy catalysing prodrug extracellular conversion
05/30/1996CA2205583A1 Method of making a library of compounds
05/30/1996CA2205540A1 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells
05/30/1996CA2205532A1 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
05/30/1996CA2205356A1 Modified proteinase inhibitors
05/30/1996CA2205130A1 Immunogens for stimulating mucosal immunity
05/30/1996CA2205061A1 Selective acylation of .epsilon.-amino groups
1 ... 2785 2786 2787 2788 2789 2790 2791 2792 2793 2794 2795 2796 2797 2798 2799 2800 2801 2802 2803 2804 2805 ... 3163